# T. ROWE PRICE EQUITY SERIES, INC.

T. ROWE PRICE EQUITY SERIES, INC. (CIK 918294) is an SEC-registered fund company with 7 reporting fund series and $4.9B in net assets as of 2026-03-31.

## Registrant

- CIK: 918294
- File number: 811-07143
- LEI: 549300U8GAQGX2UFFV03
- Address: 1307 Point Street, Baltimore, US-MD, 21231
- Phone: 410-345-2000
- Net assets: $4.9B
- Total assets: $4.9B
- Fund series: 7
- Latest report: 2026-03-31

## Fund series (7)

| Series | Net assets |
| --- | --- |
| [T. Rowe Price Blue Chip Growth Portfolio](https://search.stillhousedata.com/fund/S000002081) | $2.3B |
| [T. Rowe Price Equity Income Portfolio](https://search.stillhousedata.com/fund/S000002077) | $823.4M |
| [T. Rowe Price Health Sciences Portfolio](https://search.stillhousedata.com/fund/S000002083) | $662.6M |
| [T. Rowe Price All-Cap Opportunities Portfolio](https://search.stillhousedata.com/fund/S000002078) | $500.7M |
| [T. Rowe Price Mid-Cap Growth Portfolio](https://search.stillhousedata.com/fund/S000002080) | $429.6M |
| [T. Rowe Price Moderate Allocation Portfolio](https://search.stillhousedata.com/fund/S000002079) | $216.2M |
| [T. Rowe Price Equity Index 500 Portfolio](https://search.stillhousedata.com/fund/S000002082) | $22.0M |

## Largest reported holdings (across all series)

| Holding | Value |
| --- | --- |
| [ELI LILLY & CO](https://search.stillhousedata.com/security/532457108) | $67.7M |
| [THERMO FISHER SCIENTIFIC INC](https://search.stillhousedata.com/security/883556102) | $27.0M |
| [INTUITIVE SURGICAL INC](https://search.stillhousedata.com/security/46120E602) | $24.4M |
| [STRYKER CORP](https://search.stillhousedata.com/security/863667101) | $23.1M |
| [MERCK & CO. INC.](https://search.stillhousedata.com/security/58933Y105) | $22.9M |
| ASTRAZENECA PLC | $21.0M |
| [UNITEDHEALTH GROUP INC](https://search.stillhousedata.com/security/91324P102) | $20.5M |
| [ARGENX SE - ADR](https://search.stillhousedata.com/security/04016X101) | $19.4M |
| [ABBVIE INC](https://search.stillhousedata.com/security/00287Y109) | $19.1M |
| [REGENERON PHARMACEUTICALS](https://search.stillhousedata.com/security/75886F107) | $17.8M |
| [GILEAD SCIENCES INC](https://search.stillhousedata.com/security/375558103) | $17.3M |
| [JOHNSON & JOHNSON](https://search.stillhousedata.com/security/478160104) | $16.3M |
| [VERTEX PHARMACEUTICALS INC](https://search.stillhousedata.com/security/92532F100) | $16.1M |
| [DANAHER CORP](https://search.stillhousedata.com/security/235851102) | $13.6M |
| [ALNYLAM PHARMACEUTICALS INC](https://search.stillhousedata.com/security/02043Q107) | $10.8M |

## More

- [CIK 918294 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=918294&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/registrant/918294.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.